hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_11168.1
Confidence: Medium  
ProteinsGenename | Protein Name | Uniprot Annotation Score | Links |
---|---|---|---|
E2F5 | Transcription factor E2F5 (E2F-5) | 5 | UniProt   NCBI |
RBL2 | Retinoblastoma-like protein 2 (130 kDa retinoblastoma-associated protein) (p130) (Retinoblastoma-related protein 2) (RBR-2) (pRb2) | 5 | UniProt   NCBI |
LIN52 | Protein lin-52 homolog | 3 | UniProt   NCBI |
RBL1 | Retinoblastoma-like protein 1 (107 kDa retinoblastoma-associated protein) (p107) (pRb1) | 5 | UniProt   NCBI |
TFDP2 | Transcription factor Dp-2 (E2F dimerization partner 2) | 5 | UniProt   NCBI |
E2F1 | Transcription factor E2F1 (E2F-1) (PBR3) (Retinoblastoma-associated protein 1) (RBAP-1) (Retinoblastoma-binding protein 3) (RBBP-3) (pRB-binding protein E2F-1) | 5 | UniProt   NCBI |
E2F4 | Transcription factor E2F4 (E2F-4) | 5 | UniProt   NCBI |
LIN37 | Protein lin-37 homolog (Antolefinin) | 5 | UniProt   NCBI |
LIN54 | Protein lin-54 homolog (CXC domain-containing protein 1) | 5 | UniProt   NCBI |
E2F2 | Transcription factor E2F2 (E2F-2) | 5 | UniProt   NCBI |
MYBL2 | Myb-related protein B (B-Myb) (Myb-like protein 2) | 5 | UniProt   NCBI |
MYBL1 | Myb-related protein A (A-Myb) (Myb-like protein 1) | 5 | UniProt   NCBI |
MCIDAS | Multicilin (Multiciliate differentiation and DNA synthesis-associated cell cycle protein) (McIdas protein) (Protein Idas) | 5 | UniProt   NCBI |
LIN9 | Protein lin-9 homolog (HuLin-9) (hLin-9) (Beta subunit-associated regulator of apoptosis) (TUDOR gene similar protein) (Type I interferon receptor beta chain-associated protein) (pRB-associated protein) | 5 | UniProt   NCBI |
RB1 | Retinoblastoma-associated protein (p105-Rb) (p110-RB1) (pRb) (Rb) (pp110) | 5 | UniProt   NCBI |
E2F3 | Transcription factor E2F3 (E2F-3) | 5 | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  REAC:R-HSA-1362300 | 1.16742835189e-23 | 0.692307692308 | E2F1 LIN54 E2F4 RBL2 LIN37 RBL1 TFDP2 E2F5 LIN9 | Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 |
  REAC:R-HSA-1362277 | 1.1332345532e-22 | 0.692307692308 | E2F1 LIN54 E2F4 RBL2 LIN37 RBL1 TFDP2 E2F5 LIN9 | Transcription of E2F targets under negative control by DREAM complex |
  REAC:R-HSA-453279 | 2.39134249052e-21 | 0.923076923077 | E2F1 LIN54 E2F4 RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | Mitotic G1 phase and G1/S transition |
  REAC:R-HSA-1538133 | 7.26834022312e-21 | 0.692307692308 | E2F1 LIN54 E2F4 RBL2 LIN37 RBL1 TFDP2 E2F5 LIN9 | G0 and Early G1 |
  REAC:R-HSA-69205 | 1.08998204166e-20 | 0.692307692308 | E2F1 LIN54 E2F4 RBL2 LIN37 RBL1 TFDP2 E2F5 LIN9 | G1/S-Specific Transcription |
  KEGG:04218 | 1.83526759842e-19 | 0.846153846154 | E2F1 E2F4 RBL2 E2F3 E2F5 RBL1 RB1 E2F2 LIN54 LIN37 LIN9 | Cellular senescence |
  REAC:R-HSA-69231 | 2.55019300185e-18 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | Cyclin D associated events in G1 |
  REAC:R-HSA-69236 | 2.55019300185e-18 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | G1 Phase |
  REAC:R-HSA-69206 | 1.66634622143e-16 | 0.769230769231 | E2F1 LIN54 E2F4 RBL2 LIN37 RBL1 RB1 TFDP2 E2F5 LIN9 | G1/S Transition |
  REAC:R-HSA-69202 | 6.72328454306e-16 | 0.692307692308 | E2F1 LIN54 E2F4 RBL2 E2F5 RB1 TFDP2 LIN37 LIN9 | Cyclin E associated events during G1/S transition |
  REAC:R-HSA-69656 | 8.44171783538e-16 | 0.692307692308 | E2F1 LIN54 E2F4 RBL2 E2F5 RB1 TFDP2 LIN37 LIN9 | Cyclin A:Cdk2-associated events at S phase entry |
  WP:WP5180 | 2.99369365988e-15 | 0.615384615385 | LIN54 E2F4 RBL2 LIN37 RBL1 TFDP2 E2F5 LIN9 | DYRK1A involvement regarding cell proliferation in brain development |
  WP:WP179 | 7.41557049434e-15 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | Cell cycle |
  REAC:R-HSA-69278 | 1.43690321658e-14 | 0.923076923077 | E2F1 LIN54 E2F4 RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | Cell Cycle, Mitotic |
  KEGG:04110 | 4.16516148809e-14 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | Cell cycle |
  CORUM:5596 | 7.80900880046e-14 | 0.384615384615 | LIN9 RBL2 LIN54 E2F4 LIN37 | LINC complex, quiescent cells |
  REAC:R-HSA-1640170 | 1.7511803312e-13 | 0.923076923077 | E2F1 LIN54 E2F4 RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | Cell Cycle |
  REAC:R-HSA-69242 | 3.19902893508e-13 | 0.692307692308 | E2F1 LIN54 E2F4 RBL2 E2F5 RB1 TFDP2 LIN37 LIN9 | S Phase |
  CORUM:5589 | 1.05641911521e-10 | 0.307692307692 | LIN9 RBL1 LIN37 LIN54 | LINC complex, S-phase |
  REAC:R-HSA-9659787 | 3.89720180039e-10 | 0.384615384615 | TFDP2 E2F3 E2F2 RB1 E2F1 | Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects |
  REAC:R-HSA-9661069 | 3.89720180039e-10 | 0.384615384615 | TFDP2 E2F3 E2F2 RB1 E2F1 | Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) |
  GO:0005667 | 9.46440875379e-10 | 0.769230769231 | E2F1 E2F4 RBL2 E2F3 LIN54 RBL1 RB1 E2F2 TFDP2 E2F5 | transcription regulator complex |
  REAC:R-HSA-2559585 | 1.48385650593e-08 | 0.384615384615 | TFDP2 E2F3 E2F2 RB1 E2F1 | Oncogene Induced Senescence |
  REAC:R-HSA-9687139 | 2.0277885345e-08 | 0.384615384615 | TFDP2 E2F3 E2F2 RB1 E2F1 | Aberrant regulation of mitotic cell cycle due to RB1 defects |
  REAC:R-HSA-9675126 | 2.72030893995e-08 | 0.384615384615 | TFDP2 E2F3 E2F2 RB1 E2F1 | Diseases of mitotic cell cycle |
  REAC:R-HSA-6791312 | 7.59681560682e-08 | 0.384615384615 | RBL2 TFDP2 E2F4 E2F1 RBL1 | TP53 Regulates Transcription of Cell Cycle Genes |
  CORUM:5593 | 1.23488636402e-07 | 0.230769230769 | LIN9 LIN37 LIN54 | LINC core complex |
  WP:WP45 | 2.00951313738e-07 | 0.384615384615 | TFDP2 E2F3 E2F2 RB1 E2F1 | G1 to S cell cycle control |
  REAC:R-HSA-6804114 | 2.43115552171e-07 | 0.307692307692 | RBL2 TFDP2 E2F4 RBL1 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest |
  CORUM:5117 | 3.08563128138e-07 | 0.230769230769 | RBL2 E2F5 E2F4 | RBL2 complex (DNMT1, E2F4, E2F5, HDAC1, SUV39H1, RBL2) |
  CORUM:2975 | 3.08563128138e-07 | 0.230769230769 | RBL1 E2F5 E2F4 | SMAD3-E2F4/5-p107-DP1 complex |
  CORUM:1474 | 6.16809486722e-07 | 0.230769230769 | RBL1 E2F5 E2F4 | SMAD3/4-E2F4/5-p107-DP1 complex |
  CORUM:5118 | 6.16809486722e-07 | 0.230769230769 | RBL2 E2F5 E2F4 | RBL2 complex (E2F4, E2F5, HDAC1, SUV39H1, P300, RBL2) |
  WP:WP2446 | 9.08681163422e-07 | 0.384615384615 | TFDP2 E2F3 E2F2 RB1 E2F1 | Retinoblastoma gene in cancer |
  KEGG:05219 | 1.24812223281e-06 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Bladder cancer |
  WP:WP236 | 2.74721431007e-06 | 0.384615384615 | RBL2 E2F4 E2F1 RB1 RBL1 | Adipogenesis |
  REAC:R-HSA-2173796 | 5.9609772212e-06 | 0.307692307692 | RBL1 E2F4 E2F5 TFDP2 | SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
  GO:0090575 | 7.70462433135e-06 | 0.538461538462 | E2F1 E2F4 E2F3 RB1 E2F2 TFDP2 E2F5 | RNA polymerase II transcription regulator complex |
  KEGG:05218 | 1.16692731435e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Melanoma |
  WP:WP53 | 1.40653969659e-05 | 0.230769230769 | RBL2 RB1 RBL1 | ID signaling pathway |
  KEGG:05223 | 1.69852838622e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Non-small cell lung cancer |
  KEGG:05214 | 1.69852838622e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Glioma |
  WP:WP4685 | 2.08507558964e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Melanoma |
  GO:0001067 | 2.08852058507e-05 | 0.769230769231 | E2F1 E2F4 RBL2 E2F3 LIN54 RBL1 RB1 E2F2 TFDP2 E2F5 | transcription regulatory region nucleic acid binding |
  KEGG:05212 | 2.14146744681e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Pancreatic cancer |
  REAC:R-HSA-2173793 | 2.31450505854e-05 | 0.307692307692 | RBL1 E2F4 E2F5 TFDP2 | Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
  KEGG:05220 | 2.39270815029e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Chronic myeloid leukemia |
  WP:WP4255 | 3.26607452266e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Non small cell lung cancer |
  KEGG:01522 | 3.62278994384e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Endocrine resistance |
  CORUM:1250 | 4.10333215354e-05 | 0.153846153846 | E2F1 RB1 | RB-E2F1 complex |
  CORUM:5099 | 4.10333215354e-05 | 0.153846153846 | RB1 E2F4 | RB1(hypophosphorylated)-E2F4 complex |
  CORUM:5143 | 4.10333215354e-05 | 0.153846153846 | E2F1 RB1 | RB-E2F1 complex |
  CORUM:5159 | 4.10333215354e-05 | 0.153846153846 | RBL1 E2F4 | E2F4-p107-cyclinE complex |
  CORUM:5160 | 4.10333215354e-05 | 0.153846153846 | RBL2 E2F4 | E2F4-p130 complex |
  CORUM:5656 | 4.10333215354e-05 | 0.153846153846 | E2F1 RB1 | CEBPE-E2F1-RB1 complex |
  GO:0003677 | 4.15806009546e-05 | 0.846153846154 | E2F1 E2F4 RBL2 E2F3 LIN54 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | DNA binding |
  REAC:R-HSA-113501 | 4.27430012802e-05 | 0.230769230769 | TFDP2 RB1 E2F1 | Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
  KEGG:05222 | 4.38978472079e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Small cell lung cancer |
  KEGG:05215 | 5.2716193882e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Prostate cancer |
  REAC:R-HSA-156711 | 6.79304263505e-05 | 0.230769230769 | LIN9 LIN37 LIN54 | Polo-like kinase mediated events |
  WP:WP4263 | 7.0405442475e-05 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Pancreatic adenocarcinoma pathway |
  REAC:R-HSA-2559583 | 7.56364807749e-05 | 0.384615384615 | TFDP2 E2F3 E2F2 RB1 E2F1 | Cellular Senescence |
  WP:WP4658 | 0.000102915876951 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Small cell lung cancer |
  GO:0035189 | 0.000109904886398 | 0.230769230769 | E2F1 RB1 E2F2 | Rb-E2F complex |
  REAC:R-HSA-453274 | 0.000116848819066 | 0.384615384615 | LIN9 E2F1 E2F3 LIN37 LIN54 | Mitotic G2-G2/M phases |
  CORUM:5144 | 0.00012303818858 | 0.153846153846 | RBL1 E2F1 | E2F1-p107-cyclinA complex |
  CORUM:1661 | 0.00012303818858 | 0.153846153846 | RBL1 E2F4 | E2F4-p107-cyclinA complex |
  CORUM:1488 | 0.00012303818858 | 0.153846153846 | E2F1 RB1 | DNMT1-RB1-HDAC1-E2F1 complex |
  CORUM:1473 | 0.00012303818858 | 0.153846153846 | RBL2 E2F5 | E2F5-RB2-DP1 complex |
  KEGG:04934 | 0.000196510562353 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Cushing syndrome |
  KEGG:05224 | 0.000209346257122 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Breast cancer |
  REAC:R-HSA-170834 | 0.000219649400377 | 0.307692307692 | RBL1 E2F4 E2F5 TFDP2 | Signaling by TGF-beta Receptor Complex |
  REAC:R-HSA-113510 | 0.000229093302057 | 0.230769230769 | TFDP2 RB1 E2F1 | E2F mediated regulation of DNA replication |
  KEGG:05226 | 0.000236871836576 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Gastric cancer |
  KEGG:05160 | 0.000236871836576 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Hepatitis C |
  GO:0010468 | 0.000247117293589 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | regulation of gene expression |
  WP:WP366 | 0.000329776436244 | 0.307692307692 | RBL2 E2F4 E2F5 RBL1 | TGF beta signaling pathway |
  GO:0000977 | 0.000346455879291 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
  GO:0010556 | 0.000370272384588 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | regulation of macromolecule biosynthetic process |
  KEGG:05161 | 0.000384717586203 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Hepatitis B |
  CORUM:1471 | 0.00040971577212 | 0.153846153846 | RBL2 E2F5 | pRb2/p130-multimolecular complex (RB2, E2F5, HDAC1, SUV39H1, P300) |
  GO:0031326 | 0.000492892767642 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | regulation of cellular biosynthetic process |
  REAC:R-HSA-2559580 | 0.000504232320379 | 0.307692307692 | TFDP2 E2F2 E2F3 E2F1 | Oxidative Stress Induced Senescence |
  KEGG:05225 | 0.000511155600905 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Hepatocellular carcinoma |
  WP:WP4262 | 0.000513779613998 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Breast cancer pathway |
  REAC:R-HSA-9006936 | 0.000523366871463 | 0.307692307692 | RBL1 E2F4 E2F5 TFDP2 | Signaling by TGFB family members |
  GO:0009889 | 0.000532309914801 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | regulation of biosynthetic process |
  CORUM:6444 | 0.000614265253436 | 0.153846153846 | RBL2 RBL1 | SMAR1-HDAC1-SIN3A-SIN3B-p107-p130 repressor complex |
  KEGG:05167 | 0.000635557324889 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Kaposi sarcoma-associated herpesvirus infection |
  GO:0005654 | 0.000642773776147 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | nucleoplasm |
  GO:0000785 | 0.000688413598146 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | chromatin |
  GO:0000976 | 0.000733192108642 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | transcription cis-regulatory region binding |
  KEGG:05169 | 0.000834586097891 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Epstein-Barr virus infection |
  KEGG:05163 | 0.00107625857485 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Human cytomegalovirus infection |
  GO:1990837 | 0.00110633674183 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | sequence-specific double-stranded DNA binding |
  GO:0032993 | 0.00115449882113 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | protein-DNA complex |
  KEGG:05166 | 0.00121477388075 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Human T-cell leukemia virus 1 infection |
  GO:0031981 | 0.00148875347378 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | nuclear lumen |
  GO:0043550 | 0.00153551162834 | 0.230769230769 | RBL2 RB1 RBL1 | regulation of lipid kinase activity |
  GO:0001216 | 0.00174559545982 | 0.461538461538 | E2F1 E2F4 E2F5 E2F2 TFDP2 E2F3 | DNA-binding transcription activator activity |
  REAC:R-HSA-3700989 | 0.00193896131662 | 0.384615384615 | RBL2 TFDP2 E2F4 E2F1 RBL1 | Transcriptional Regulation by TP53 |
  REAC:R-HSA-68911 | 0.00199260676058 | 0.153846153846 | E2F1 E2F3 | G2 Phase |
  REAC:R-HSA-111448 | 0.00199260676058 | 0.153846153846 | TFDP2 E2F1 | Activation of NOXA and translocation to mitochondria |
  GO:0043565 | 0.00206809318276 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | sequence-specific DNA binding |
  GO:0003690 | 0.00211783150724 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | double-stranded DNA binding |
  GO:0140513 | 0.00213464356125 | 0.692307692308 | E2F1 E2F4 LIN37 E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 | nuclear protein-containing complex |
  CORUM:5611 | 0.00224666054346 | 0.153846153846 | RBL2 RB1 | Emerin complex 24 |
  REAC:R-HSA-212436 | 0.00263447397095 | 0.538461538462 | E2F1 E2F4 RBL2 RBL1 RB1 TFDP2 E2F5 | Generic Transcription Pathway |
  WP:000000 | 0.00311598470754 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | WIKIPATHWAYS |
  KEGG:04350 | 0.00319307127413 | 0.230769230769 | RBL1 E2F5 E2F4 | TGF-beta signaling pathway |
  GO:0006355 | 0.00430535344115 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | regulation of DNA-templated transcription |
  GO:2001141 | 0.00459246252839 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | regulation of RNA biosynthetic process |
  GO:0060255 | 0.00504267470121 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | regulation of macromolecule metabolic process |
  GO:0006357 | 0.00505431373159 | 0.769230769231 | E2F1 E2F4 MCIDAS E2F3 LIN37 RB1 E2F2 TFDP2 E2F5 LIN9 | regulation of transcription by RNA polymerase II |
  GO:0031323 | 0.00519983036922 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | regulation of cellular metabolic process |
  REAC:R-HSA-73857 | 0.00544250481316 | 0.538461538462 | E2F1 E2F4 RBL2 RBL1 RB1 TFDP2 E2F5 | RNA Polymerase II Transcription |
  KEGG:05165 | 0.00568635345795 | 0.307692307692 | RBL2 E2F1 RB1 RBL1 | Human papillomavirus infection |
  CORUM:5614 | 0.00695708221026 | 0.153846153846 | RBL2 RBL1 | Emerin complex 32 |
  GO:0006351 | 0.00713701566553 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | DNA-templated transcription |
  REAC:R-HSA-139915 | 0.00715899645867 | 0.153846153846 | TFDP2 E2F1 | Activation of PUMA and translocation to mitochondria |
  WP:WP2431 | 0.00721580476655 | 0.230769230769 | E2F1 E2F5 RB1 | Spinal cord injury |
  GO:0010467 | 0.0074734456447 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | gene expression |
  WP:WP3969 | 0.0077180657803 | 0.153846153846 | E2F1 RB1 | H19 action Rb E2F1 signaling and CDK Beta catenin activity |
  GO:0032774 | 0.00799764715634 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | RNA biosynthetic process |
  GO:0006366 | 0.00845149473208 | 0.769230769231 | E2F1 E2F4 MCIDAS E2F3 LIN37 RB1 E2F2 TFDP2 E2F5 LIN9 | transcription by RNA polymerase II |
  REAC:R-HSA-1912408 | 0.0101717446382 | 0.230769230769 | TFDP2 E2F3 E2F1 | Pre-NOTCH Transcription and Translation |
  GO:0000082 | 0.01096382655 | 0.384615384615 | RBL2 E2F3 E2F1 RB1 RBL1 | G1/S transition of mitotic cell cycle |
  REAC:R-HSA-74160 | 0.0123811504483 | 0.538461538462 | E2F1 E2F4 RBL2 RBL1 RB1 TFDP2 E2F5 | Gene expression (Transcription) |
  GO:0051252 | 0.0141643501886 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | regulation of RNA metabolic process |
  GO:0019222 | 0.0152524190501 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | regulation of metabolic process |
  KEGG:05206 | 0.0154550895581 | 0.230769230769 | E2F1 E2F3 E2F2 | MicroRNAs in cancer |
  GO:0005694 | 0.016278404599 | 0.692307692308 | E2F1 E2F4 RBL2 E2F3 RBL1 RB1 E2F2 TFDP2 E2F5 | chromosome |
  REAC:R-HSA-1912422 | 0.0180213476636 | 0.230769230769 | TFDP2 E2F3 E2F1 | Pre-NOTCH Expression and Processing |
  GO:0044843 | 0.0202942453403 | 0.384615384615 | RBL2 E2F3 E2F1 RB1 RBL1 | cell cycle G1/S phase transition |
  GO:0009059 | 0.0217204773108 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | macromolecule biosynthetic process |
  GO:0070013 | 0.0244298182677 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | intracellular organelle lumen |
  GO:0031974 | 0.0244298182677 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | membrane-enclosed lumen |
  GO:0043233 | 0.0244298182677 | 1.0 | E2F1 LIN54 E2F4 MCIDAS RBL2 E2F3 LIN37 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | organelle lumen |
  KEGG:05200 | 0.028109729248 | 0.307692307692 | E2F1 E2F3 RB1 E2F2 | Pathways in cancer |
  GO:0003676 | 0.0286323529083 | 0.846153846154 | E2F1 E2F4 RBL2 E2F3 LIN54 RBL1 RB1 E2F2 TFDP2 E2F5 LIN9 | nucleic acid binding |
  KEGG:05203 | 0.0302093677775 | 0.230769230769 | RBL2 RB1 RBL1 | Viral carcinogenesis |
  GO:0034654 | 0.0303256217626 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | nucleobase-containing compound biosynthetic process |
  WP:WP5121 | 0.031835197324 | 0.153846153846 | E2F1 RB1 | Sphingolipid metabolism in senescence |
  GO:0018130 | 0.0367791392248 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | heterocycle biosynthetic process |
  GO:0019438 | 0.0371946868599 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | aromatic compound biosynthetic process |
  GO:0019219 | 0.0373341395785 | 0.846153846154 | E2F1 E2F4 LIN37 MCIDAS E2F3 E2F5 RB1 E2F2 TFDP2 LIN54 LIN9 | regulation of nucleobase-containing compound metabolic process |
  WP:WP5202 | 0.0416894057602 | 0.153846153846 | TFDP2 E2F4 | Alstrom syndrome |
  WP:WP2828 | 0.0499352504887 | 0.153846153846 | E2F1 RB1 | Bladder cancer |
  CORUM:5663 | 0.0499717467432 | 0.0769230769231 | RB1 | TRIM27-RB1 complex |
  CORUM:839 | 0.0499717467432 | 0.0769230769231 | LIN9 | LIN9-BMYB complex |
Edges
Protein 1 | Protein 2 | Score | ProteomeHD |
---|---|---|---|
 LIN37 |  LIN54 | 1.0 | 0.148           |
 LIN37 |  LIN9 | 1.0 | 0.174           |
 LIN52 |  LIN9 | 1.0 | 0.198           |
 LIN37 |  MYBL2 | 1.0 | 0.164           |
 LIN54 |  LIN9 | 1.0 | 0.324           |
 LIN52 |  LIN37 | 1.0 | 0.18           |
 MYBL2 |  LIN9 | 1.0 | 0.248           |
 MYBL1 |  LIN9 | 0.999 |            |
 LIN37 |  MYBL1 | 0.999 |            |
 LIN52 |  MYBL1 | 0.999 |            |
 E2F4 |  TFDP2 | 0.998 | 0.16           |
 LIN52 |  LIN54 | 0.998 | 0.21           |
 E2F5 |  TFDP2 | 0.998 |            |
 TFDP2 |  E2F2 | 0.997 |            |
 LIN54 |  MYBL1 | 0.997 |            |
 RBL2 |  RBL1 | 0.996 | 0.118           |
 TFDP2 |  E2F3 | 0.996 | 0.152           |
 TFDP2 |  E2F1 | 0.991 |            |
 LIN52 |  MYBL2 | 0.99 | 0.184           |
 MCIDAS |  TFDP2 | 0.985 |            |
 LIN37 |  E2F5 | 0.983 |            |
 E2F4 |  E2F5 | 0.974 |            |
 LIN9 |  TFDP2 | 0.972 | 0.226           |
 E2F4 |  LIN37 | 0.969 | 0.146           |
 LIN37 |  TFDP2 | 0.967 | 0.164           |
 LIN37 |  RBL1 | 0.967 | 0.16           |
 RBL2 |  TFDP2 | 0.967 | 0.122           |
 MYBL2 |  MYBL1 | 0.967 |            |
 LIN54 |  TFDP2 | 0.966 | 0.182           |
 RBL1 |  TFDP2 | 0.966 | 0.158           |
 RBL2 |  LIN37 | 0.965 | 0.08           |
 LIN54 |  MYBL2 | 0.965 | 0.206           |
 RB1 |  TFDP2 | 0.963 | 0.206           |
 LIN52 |  TFDP2 | 0.962 | 0.2           |
 RBL1 |  LIN9 | 0.962 | 0.184           |
 E2F2 |  E2F3 | 0.961 |            |
 RBL2 |  LIN9 | 0.96 | 0.122           |
 E2F5 |  E2F2 | 0.959 |            |
 E2F4 |  LIN9 | 0.941 | 0.108           |
 E2F4 |  E2F3 | 0.936 | 0.174           |
 RB1 |  E2F2 | 0.926 |            |
 E2F5 |  E2F3 | 0.924 |            |
 E2F4 |  E2F2 | 0.917 |            |
 MCIDAS |  E2F2 | 0.902 |            |
 MCIDAS |  E2F3 | 0.902 |            |
 LIN52 |  E2F2 | 0.902 |            |
 E2F4 |  RB1 | 0.9 | 0.162           |
 LIN9 |  E2F2 | 0.892 |            |
 LIN52 |  MCIDAS | 0.892 |            |
 MCIDAS |  E2F5 | 0.892 |            |
 RB1 |  E2F3 | 0.888 | 0.136           |
 RBL1 |  RB1 | 0.877 | 0.216           |
 LIN54 |  E2F2 | 0.869 |            |
 E2F4 |  MCIDAS | 0.76 |            |
 LIN9 |  MCIDAS | 0.754 |            |
 RB1 |  E2F5 | 0.751 |            |
 LIN54 |  MCIDAS | 0.715 |            |
 RBL1 |  E2F2 | 0.703 |            |
 LIN52 |  E2F3 | 0.688 | 0.138           |
 RBL2 |  E2F2 | 0.676 |            |
 MCIDAS |  RB1 | 0.634 |            |
 LIN54 |  E2F5 | 0.633 |            |
 LIN52 |  E2F5 | 0.633 |            |
 E2F4 |  MYBL1 | 0.616 |            |
 MYBL1 |  TFDP2 | 0.616 |            |
 RBL2 |  MYBL1 | 0.616 |            |
 E2F4 |  MYBL2 | 0.616 | 0.214           |
 MYBL2 |  RBL1 | 0.616 | 0.238           |
 RBL1 |  MYBL1 | 0.616 |            |
 MYBL2 |  TFDP2 | 0.616 | 0.218           |
 RBL2 |  MYBL2 | 0.616 | 0.12           |
 E2F1 |  E2F3 | 0.582 |            |
 E2F1 |  E2F2 | 0.568 |            |
 E2F5 |  E2F1 | 0.541 |            |
 E2F4 |  RBL1 | 0.526 | 0.154           |
 E2F4 |  RBL2 | 0.524 | 0.09           |
 RBL1 |  E2F3 | 0.468 | 0.138           |
 RBL1 |  MCIDAS | 0.455 |            |
 LIN9 |  E2F5 | 0.428 |            |
 RBL2 |  E2F3 | 0.418 | 0.12           |
 RBL2 |  MCIDAS | 0.405 |            |
 LIN52 |  RBL2 | 0.404 | 0.066           |
 E2F4 |  LIN52 | 0.404 | 0.128           |
 RBL2 |  E2F5 | 0.404 |            |
 LIN52 |  RBL1 | 0.404 | 0.108           |
 MYBL2 |  E2F5 | 0.388 |            |
 MYBL1 |  E2F5 | 0.388 |            |
 RBL1 |  E2F5 | 0.384 |            |
 E2F4 |  E2F1 | 0.378 |            |
 LIN54 |  RBL1 | 0.372 | 0.206           |
 RBL2 |  LIN54 | 0.36 | 0.128           |
 LIN9 |  E2F3 | 0.357 | 0.162           |
 E2F4 |  LIN54 | 0.352 | 0.11           |
 LIN54 |  E2F3 | 0.341 | 0.17           |
 RBL2 |  RB1 | 0.282 | 0.158           |
 LIN52 |  RB1 | 0.261 | 0.15           |
 LIN9 |  RB1 | 0.258 | 0.132           |
 LIN52 |  E2F1 | 0.214 |            |
 MCIDAS |  E2F1 | 0.214 |            |
 LIN54 |  RB1 | 0.196 | 0.156           |
 RB1 |  E2F1 | 0.149 |            |
 RBL1 |  E2F1 | 0.146 |            |
 LIN9 |  E2F1 | 0.131 |            |
 RBL2 |  E2F1 | 0.131 |            |
 LIN54 |  E2F1 | 0.108 |            |
 MYBL2 |  E2F3 | 0.022 | 0.138           |
 LIN37 |  RB1 | 0.016 | 0.182           |
 MYBL2 |  RB1 | 0.013 | 0.078           |
Related Complexes